Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

241 recalls, newest first

Class II · Moderate risk

Ephedrine Plus

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation NDC 65193-320-24 D-0473-2022
Class II · Moderate risk

Chloresin

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation NDC 51532-0107-2 D-0468-2022
Class II · Moderate risk

Proctofoam HC

cGMP deficiencies

Terminated cGMP deviation Mylan Pharmaceuticals Inc NDC 0037-6822-10 D-0452-2022
Class II · Moderate risk

Lexette (halobetasol propionate)

CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

Ongoing cGMP deviation Mayne Pharma Inc NDC 51862-604-50 D-0387-2022

Recalls by year